SCHEMBL933857

SCHEMBL933857

COc1ccc(CC(C)C(N)=O)cc1

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LDHA P00338 1/20 0.61
SLC6A4 P31645 1/20 0.59
CYP2C19 P33261 2/20 0.51
CYP1A2 P05177 1/20 0.51
CYP2D6 P10635 1/20 0.51
EPHX1 P07099 2/20 0.49
ACACB O00763 1/20 0.49
POLB P06746 1/20 0.49
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
PARP1 P09874 1/20 0.48
PARP10 Q53GL7 1/20 0.48
PARP2 Q9UGN5 1/20 0.48
PARP4 Q9UKK3 1/20 0.48
ALDH1A1 P00352 2/20 0.47
CYP3A4 P08684 1/20 0.47
PPARG P37231 1/20 0.47
PPARA Q07869 1/20 0.47
HTT P42858 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27795435 0.85 LDHA (0.65) LDHASLC6A4CYP2C19CYP1A2CYP2D6
SCHEMBL3832306 0.84 LDHA (0.62) LDHASLC6A4CYP2C19CYP1A2CYP2D6
SCHEMBL663059 0.84 LDHA (0.73) LDHASLC6A4ACACBPPARGPPARA
SCHEMBL23051836 0.84 LDHA (0.62) LDHASLC6A4CYP2C19CYP1A2CYP2D6
SCHEMBL8283100 0.84 LDHA (0.73) LDHASLC6A4ACACBPPARGPPARA
SCHEMBL13780262 0.83 PARP10 (0.54) ACACBPARP10ALDH1A1
SCHEMBL1900987 0.82 LDHA (0.61) LDHASLC6A4CYP2C19CYP1A2CYP2D6
SCHEMBL1587131 0.82 LDHA (0.61) LDHASLC6A4CYP2C19CYP1A2CYP2D6
SCHEMBL3357448 0.82 LDHA (0.61) LDHASLC6A4CYP2C19CYP1A2CYP2D6
SCHEMBL1587128 0.82 LDHA (0.61) LDHASLC6A4CYP2C19CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114736197-B Imidazolidinone derivatives and their use 南京医工医药技术有限公司 2022-09-13 CN disclosed
CN-107820429-B Novel compositions and methods for immunotherapy comprising small molecule integrin receptor-ligand agonist adjuvants 7山药物有限责任公司 2022-08-16 CN disclosed
CN-114736197-A Imidazolidinone derivatives and their use 南京医工医药技术有限公司 2022-07-12 CN disclosed
US-8163761-B2 Methods and compositions for treating disorders HYDRA BIOSCIENCES, INC. (US) 2012-04-24 US disclosed
WO-2011006935-A2 TETRAZOLE DERIVATIVES MERCK SERONO S.A. (CH) 2011-01-20 WO disclosed